NAVIDEA BIOPHARMACEUTICALS I's ticker is and the CUSIP is 63937X953. A total of 2 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 1 | -97.3% | 0.00% | – |
Q3 2016 | $1,000 | -66.7% | 37 | -57.5% | 0.00% | – |
Q2 2016 | $3,000 | +200.0% | 87 | +74.0% | 0.00% | – |
Q1 2016 | $1,000 | – | 50 | +525.0% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 8 | -96.2% | 0.00% | – |
Q3 2015 | $1,000 | -90.9% | 208 | +4.0% | 0.00% | -100.0% |
Q2 2015 | $11,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $11,000 | +1000.0% | 200 | +387.8% | 0.00% | – |
Q4 2014 | $1,000 | – | 41 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 63,100 | $168,000 | 0.00% |
Citadel Advisors | 33,800 | $90,000 | 0.00% |